Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 236-655-6 | CAS number: 13455-36-2
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Skin irritation / corrosion
Administrative data
- Endpoint:
- skin irritation: in vitro / ex vivo
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 2022-01-26 to 2022-04-15
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 022
- Report date:
- 2022
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 439 (In Vitro Skin Irritation: Reconstructed Human Epidermis Test Method)
- Version / remarks:
- adopted 14 June 2021
- GLP compliance:
- yes (incl. QA statement)
Test material
- Reference substance name:
- Tricobalt bis(orthophosphate)
- EC Number:
- 236-655-6
- EC Name:
- Tricobalt bis(orthophosphate)
- Cas Number:
- 13455-36-2
- Molecular formula:
- Co3(PO4)2
- IUPAC Name:
- tricobalt bis(orthophosphate)
- Reference substance name:
- Dicobalt diphosphate
- EC Number:
- 238-689-7
- EC Name:
- Dicobalt diphosphate
- Cas Number:
- 14640-56-3
- Molecular formula:
- Co2P2O7
- IUPAC Name:
- dicobalt diphosphate
- Reference substance name:
- cobalt phosphate octahydrate
- Cas Number:
- 10294-50-5
- Molecular formula:
- Co3(PO4)2.8H2O
- IUPAC Name:
- cobalt phosphate octahydrate
- Test material form:
- solid: particulate/powder
Constituent 1
impurity 1
impurity 2
In vitro test system
- Test system:
- human skin model
Test animals
- Details on test animals or test system and environmental conditions:
- Not applicable - Since this is an in-vitro study there is no information on test animals.
Test system
- Type of coverage:
- open
- Vehicle:
- unchanged (no vehicle)
- Controls:
- yes, concurrent positive control
- yes, concurrent negative control
- Amount / concentration applied:
- The test item was applied, as supplied, at the dose of 16 mg to the epidermal surface of 3 living and 2 killed human skin models during 42 minutes at room temperature. The Reconstructed Human epidermis had been previously moistened with 10 µL of distilled water.
In the same experimental conditions, a positive control (16 µL 5% sodium dodecyl sulfate - SDS) and a negative control (16 µL of distilled water - ADL Prochilab - batch n° 201117) were carried out. The 5% SDS solution was prepared by weighing 0.5005 g of SDS (SIGMA - batch n° STBJ3028) in a 10 mL volumetric flask qsp 10 mL of distilled water. Then, the preparation was magnetically stirred, just before the treatment to obtain a colourless solution.
To ensure good contact with the epidermises, during all the treatment period, the control items were recovered with a nylon mesh provided by Episkin SA. - Duration of treatment / exposure:
- 42 minutes
- Observation period:
- not applicable
- Number of animals:
- not applicable
- Details on study design:
- HUMAN SKIN MODEL
The 0.50 cm2 reconstructed epidermises (Episkin SA, RHE/S/17 batch n°22-RHE-032) were received on 22 February 2022. The 2 additional killed Human skin model surfaces (Episkin SA, RHE/S/17 - batch n°22-RHE-015 frozen on 25 January 2022) were defrozen the day of the tratment, on 22 February 2022.
On the same day, the inserts (filter + epidermis) was gently removed from the agarose while avoiding leaving agarose on the polycarbonate filter. The inserts were placed in 24 wells culture plate which had been previously filled with 300 µL of growth medium (Episkin SA, batch n° 22 SGM 019) for 4 hours and 24 minutes. Then just before treatment, the inserts were placed in 24 wells culture plate which had been previously filled with 300 µL of maintenance medium (Episkin SA, batch 22 SMM 009).
EVALUATION OF DIRECT INTERACTION WITH MTT
The direct interaction of MTT with the test item was checked by adding 16 mg of the test item to 300 µL of solution of MTT at 1 mg/L (same conditions as the main test). A yellow liquid with purple test item at the bottom of the well was observed after 3 hours of incubation between 36.5°C and 36.9°C, 5% CO2. > Due to the intrnisic colour of the test item (purple), the test item was identified as potentil direct MTT reducer: two additional killed control tissue models were added to the study which underwent the entire testing procedure to generate a non-specific MTT reguction (NSMTT) control.
SPECTRAL ANALYSIS OF THE TEST ITEM IN ISOPROPANOL
The spectral properties at 570 nm of test item in isopropanol ware checked by adding 16 mg of the test item to 1.5 mL of isopropanol (same conditions as in the main test). A purple suspension was obtained after 2 hours of incubation at ambient temperature with gentle shaking. The suspension was centrifuged for 1 minute at 4500 rpm before dosinig the supernatant. The mean of the corrected OD after centrifugation was 0.012 which is lower than 0.08 (value corresponding to approximately twice the OD of the extracting solvent). > Therefore, the test item will not interfere with the viability assay and there is no need to add non-specific coloration controls to the study. .
GRADING OF REACTIONS
42 minutes after the test item application, the nylon mesh was removed and the human epidermies were washed with 25 x 1 mL of DPBS (Dutscher, batch n°3730921). The rinsed tissues were checked for any coloration and noted to be white, comparable coloration to that of the negative control tissues. Purple traces were noted on the epidermises treated with the test item.
They were incubated for 42 hours and 15 minutes post-treatment incubation-period in fresh medium at 37°C, 5% CO2. Then, the epidermises were put in contact with the MTT solution.
The cell viability was quantified by measurement of the cellular mitochondrial dehydrogenase activity. This enzyme is responsible for the MTT [3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide, Thiazol blue; CAS n° 298-93-1)] reduction into blue formazan salt in the viable cells that is quantatively measured by Optical Density (OD) after extraction from tissues.
The measured OD are proportional to the number of living cells.
The skin samples were placed in 300 µL of a MTT solution at 1.0 mg/L for 2 hours and 58 minutes at 37°C..
The precipitated blue formazan product was then extracted using 700 µL of isopropanol during 2 hours under gentle agitation in the dark, and the concentration of formazan was measured by determining the OD at 570 nm, just after dilution of the extracts 1:2 in isopropanol.
The OD was measured in triplicate of MTT extract.
The measurement of OD at 570 nm of formazan extracts was performed in triplicate samples using the ELx800 absorbance microplte reader (controlled every year and calibrated if necessary) supplied by BioTek and the validated software Gen5 ELISA V1.05.11 supplied by BioTek.
TREATMENT OF THE RESULTS
The results were expressed as a viability percentage compared with the negative control:
% viability = Mean OD test item / Mean OD negative control * 100
As the test item is identified as a potential direct MTT reducer, true viability was calculated as follows:
% true viability = (Mean OD test item - Mean OD NSMTT) / Mean OD negatie control * 100
For each tissue, OD values and calculated percentage cell viability data for the test item, positive and negative controls, should be reported in tabular form, including data from replicate repeat experiments as appropriate, mean and individual values.
Results and discussion
In vitro
Results
- Irritation / corrosion parameter:
- % tissue viability
- Remarks:
- mean
- Value:
- 81.8
- Negative controls validity:
- valid
- Remarks:
- mean viability (%) = 100
- Positive controls validity:
- valid
- Remarks:
- mean viability (%) = 1.8
- Remarks on result:
- other:
- Remarks:
- Time point: after 42 min of exposure and 42 hours post-treatment incubation.
- Other effects / acceptance of results:
- - SD value of the % viability ≤ 18%
- Negative control: OD values of the 3 replicates in the range of ≥0.8 and ≤ 3.0.
- The optical density was measured after 1:2 dilution of the formazan extracts in isopropanol; the acceptability criterai should be in the range of ≥0.4 and ≤ 1.5.
- Positive control: mean viability < 40%.
Any other information on results incl. tables
Results after treatment with test item and the controls
Dose group |
Treatment |
Mean OD
|
Mean OD
|
Mean OD Skin 3*
|
Mean OD Product
|
Mean Viability % |
Negative control |
42 min |
1.097 |
0.811 |
0.974 |
0.961 |
100.0 |
Positive control |
42 min |
0.015 |
0.018 |
0.019 |
0.017 |
1.8 |
Test item |
42 min |
0.912 |
0.771 |
0699 |
0.794 |
82.7 |
Test item NSMTT |
42 min |
0.008 | 0.009 | 0.009 | 0.9 | |
Test item corrected |
|
|
|
|
|
81.8 |
OD = Optical Density
The standard deviations between the % variabilities of the test item, the positive and negative controls were respectively 11.3 - 0.2 - 14.9%. The threshold of the "OECD TG 439 Guideline for the Testing of Chemicals 439: In vitro Skin Irritation: Reconstructed Human Epidermis Test Method” is 18%.
Applicant's summary and conclusion
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- In accordance with the Regulation EC n° 1272/2008, the test item has to be considered as non-irritant to skin. It corresponds to UN GHS No Category. No hazard statement or signal word is required.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.